Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)

  • Ji Yun Lee
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Xu Qing
    Translational Bioscience and Diagnostics, WuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai, China
  • Wei Xiumin
    Translational Bioscience and Diagnostics, WuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai, China
  • Bai Yali
    Translational Bioscience and Diagnostics, WuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai, China
  • Sangah Chi
    Department of Biostatistics and Bioinformatics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • So Hyeon Bak
    Department of Radiology, Kangwon National University Hospital, Chuncheon, Korea
  • Ho Yun Lee
    Department of Radiology, Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Jong-Mu Sun
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Se-Hoon Lee
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Jin Seok Ahn
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Eun Kyung Cho
    Division of Hematology-Oncology, Department of Medicine, Gachon Medical School, Gil Medical Center, Inchon, Korea
  • Dong-Wan Kim
    Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
  • Hye Ryun Kim
    Division of Oncology, Department of Medicine, Yonsei University College of Medicine, Seoul, Korea
  • Young Joo Min
    Department of Oncology, Asan Medical Center, University of Ulsan college of Medicine, Seoul, Korea
  • Sin-Ho Jung
    Department of Biostatistics and Bioinformatics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Keunchil Park
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • Mao Mao
    Translational Bioscience and Diagnostics, WuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai, China
  • Myung-Ju Ahn
    Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

収録刊行物

  • Oncotarget

    Oncotarget 7 (6), 6984-6993, 2016-01-09

    Impact Journals, LLC

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ